1型糖尿病患者的肥胖问题
本文综述了1型糖尿病患者中超重与肥胖日益常见的现象,探讨了非生理性胰岛素替代导致外周高胰岛素血症、胰岛素方案与基础及餐时需求不匹配、为防低血糖而防御性加餐等因素对体脂过度积累的影响,并指出超重或肥胖增加糖尿病相关及肥胖相关并发症风险,包括心血管疾病、卒中和多种癌症,强调需优化该人群的预防和治疗策略。
要点
- 1型糖尿病患者中超重和肥胖日益常见。
- 非生理性胰岛素替代等因素驱动体脂过度积累。
- 超重或肥胖增加心血管疾病、卒中和癌症等并发症风险。
核心结论
- 1型糖尿病患者中超重和肥胖日益常见,并增加糖尿病相关及肥胖相关并发症风险,需优化预防和治疗策略。
研究设计与样本
- 本文为综述,总结当前对1型糖尿病患者体重过度增加病因学和后果的认识。
主要发现
- 非生理性胰岛素替代导致外周高胰岛素血症、胰岛素方案与基础及餐时需求不匹配、为防低血糖而防御性加餐等因素被认为影响体成分并驱动体脂过度积累。
- 超重或肥胖增加1型糖尿病患者糖尿病相关和肥胖相关并发症风险,包括心血管疾病、卒中和多种类型癌症。
临床怎么用
- 临床应关注1型糖尿病患者的体重管理,优化胰岛素方案和预防治疗策略以减少体脂过度积累及相关并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although type 1 diabetes is traditionally considered a disease of lean people, overweight and obesity are becoming increasingly more common in individuals with type 1 diabetes. Non-physiological insulin replacement that causes peripheral hyperinsulinaemia, insulin profiles that do not match basal and mealtime insulin needs, defensive snacking to avoid hypoglycaemia, or a combination of these, are believed to affect body composition and drive excessive accumulation of body fat in people with type 1 diabetes. The consequences of overweight or obesity in people with type 1 diabetes are of particular concern, as they increase the risk of both diabetes-related and obesity-related complications, including cardiovascular disease, stroke, and various types of cancer. In this Review, we summarise the current understanding of the aetiology and consequences of excessive bodyweight in people with type 1 diabetes and highlight the need to optimise future prevention and treatment strategies in this population.
引用
- Van der Schueren B, Ellis D, Faradji RN, et al. Obesity in people living with type 1 diabetes. Lancet Diabetes Endocrinol. 2021. PMID: 34600607. doi:10.1016/S2213-8587(21)00246-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。